Parental (KLK6 nonexpressing), C5 (KLK6 highly overexpressing), and C28 (KLK6 physiological‐expressing) MDA‐MD‐231 cells were selected for proteomic profiling to identify molecular pathways that determine their distinct tumor characteristics in relation to KLK6 levels. The gene discussed is KLK6; the disease is neoplasm.